Published in Mediators Inflamm on April 15, 2009
Aging of the innate immune system. Curr Opin Immunol (2010) 2.43
Leukocyte function in the aging immune system. J Leukoc Biol (2010) 1.32
Neutrophil heterogeneity in health and disease: a revitalized avenue in inflammation and immunity. Open Biol (2012) 1.30
Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis. Blood (2010) 1.17
An immunosuppressive antibody-drug conjugate. J Am Chem Soc (2015) 0.87
Defective CXCR4 expression in aged bone marrow cells impairs vascular regeneration. J Cell Mol Med (2011) 0.85
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med (2004) 11.71
Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science (1999) 8.43
Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest (1989) 7.60
Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol (1976) 7.06
Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol (2002) 3.61
Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity (2003) 3.55
Apoptosis in resolution of inflammation. J Leukoc Biol (1997) 2.67
Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem (1998) 2.32
Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis. Blood (2004) 2.17
Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proc Natl Acad Sci U S A (1998) 2.06
High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia. Br J Haematol (2001) 2.06
Impairment of function in aging neutrophils is associated with apoptosis. J Immunol (1993) 2.05
Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin Hematol (1997) 1.78
Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. J Immunol (1995) 1.64
Neutrophil maturation and activation determine anatomic site of clearance from circulation. Am J Physiol Lung Cell Mol Physiol (2001) 1.56
Tissue injury in neutrophilic inflammation. Inflamm Res (1997) 1.42
Regulation of cell adhesion molecule expression and function associated with neutrophil apoptosis. Blood (1995) 1.30
Role of the liver in regulating numbers of circulating neutrophils. Blood (2001) 1.25
Programmed cell death of the normal human neutrophil: an in vitro model of senescence. Microsc Res Tech (1994) 1.08
Transendothelial migration of CD34+ and mature hematopoietic cells: an in vitro study using a human bone marrow endothelial cell line. Blood (1997) 1.07
Elimination of senescent neutrophils by TNF-related apoptosis-inducing [corrected] ligand. J Immunol (2005) 1.06
Novel trends in neutrophil structure, function and development. Immunol Today (1999) 1.05
A role for apoptosis in the control of neutrophil homeostasis in the circulation: insights from CD18-deficient mice. Blood (2002) 1.02
Expression and functional analysis of chemokine receptors in human peripheral blood leukocyte populations. Cytokine (2001) 0.95
MAP kinase upregulation after hematopoietic differentiation: role of chemotaxis. Am J Physiol Cell Physiol (2001) 0.95
Apoptosis of neutrophils. Curr Opin Hematol (1996) 0.91
Characterization of the MEK5-ERK5 module in human neutrophils and its relationship to ERK1/ERK2 in the chemotactic response. J Biol Chem (2004) 0.91
The neutrophilic granulocyte. Curr Top Pathol (1989) 0.90
Macrophages in spleen and liver direct the migration pattern of rat neutrophils during inflammation. Eur J Haematol (2004) 0.82
CXCR4 undergoes complex lineage and inducing agent-dependent dissociation of expression and functional responsiveness to SDF-1alpha during myeloid differentiation. J Leukoc Biol (2001) 0.80
Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV. J Clin Oncol (2013) 4.50
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol (2010) 3.88
Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. J Clin Oncol (2011) 3.17
Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood (2002) 2.88
Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis. J Clin Oncol (2002) 2.78
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood (2003) 2.50
Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor. J Clin Oncol (2010) 2.38
Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci (2007) 2.24
Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia. J Clin Oncol (2009) 2.23
PET/CT with 18F-FLT: does it improve the therapeutic management of metastatic germ cell tumors? J Nucl Med (2010) 2.22
Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. Haematologica (2003) 2.17
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). Blood (2006) 2.15
Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells. Blood (2003) 1.99
Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach. Blood (2006) 1.85
Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica (2008) 1.80
Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer (2011) 1.74
Preoperative therapeutic plasma exchange in patients with thyrotoxicosis. J Clin Apher (2009) 1.70
Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients. Cancer Res (2006) 1.67
Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV. Blood (2011) 1.65
Primary malignant sarcomas of the heart and great vessels in adult patients--a single-center experience. Oncologist (2007) 1.63
Small bowel obstruction due to phytobezoar: CT diagnosis. Eur Radiol (2002) 1.59
Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia. Blood (2010) 1.56
Human plasma thrombopoietin levels are regulated by binding to platelet thrombopoietin receptors in vivo. Transfusion (2002) 1.52
Optimization of autologous stem cell transplantation for systemic sclerosis -- a single-center longterm experience in 26 patients with severe organ manifestations. J Rheumatol (2012) 1.46
SOX2 expression associates with stem cell state in human ovarian carcinoma. Cancer Res (2013) 1.34
Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells. Blood (2003) 1.32
Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients. Mol Ther (2010) 1.32
German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma. Ann Neurol (2002) 1.32
Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas. Haematologica (2012) 1.30
The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cells. Blood (2004) 1.29
Phenotypic characterization of distinct human bone marrow-derived MSC subsets. Ann N Y Acad Sci (2009) 1.28
Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12. Brain (2006) 1.28
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update. Blood Cells Mol Dis (2007) 1.27
Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthritis Rheum (2007) 1.25
Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signaling. Blood (2012) 1.23
Hematopoietic development from human induced pluripotent stem cells. Ann N Y Acad Sci (2009) 1.22
Central venous stenosis in haemodialysis patients without a previous history of catheter placement. Eur J Radiol (2004) 1.21
The role of sphingosine 1-phosphate receptors in the trafficking of hematopoietic progenitor cells. Ann N Y Acad Sci (2005) 1.19
Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion. Semin Hematol (2007) 1.19
NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report. Ann Neurol (2005) 1.16
Retraction: Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat Med (2003) 1.16
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study. Haematologica (2012) 1.14
Inhibitory effect of imatinib on normal progenitor cells in vitro. Blood (2003) 1.13
Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence? Am J Surg (2008) 1.13
Sunitinib and periodic hair depigmentation due to temporary c-KIT inhibition. Arch Dermatol (2008) 1.11
CDCP1 is a novel marker for hematopoietic stem cells. Ann N Y Acad Sci (2003) 1.07
Integrative prognostic risk score in acute myeloid leukemia with normal karyotype. Blood (2011) 1.07
Effect of drainage on postoperative nausea, vomiting, and pain after laparoscopic cholecystectomy. Langenbecks Arch Surg (2003) 1.06
Extragonadal germ cell tumors: relation to testicular neoplasia and management options. APMIS (2003) 1.04
Laparoscopic repair of bilateral morgagni hernia. Surg Laparosc Endosc Percutan Tech (2004) 1.03
BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells. Cancer Res (2007) 1.03
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. Haematologica (2005) 1.03
Dermatoses of the nipple. Can J Surg (2009) 1.02
In vitro myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle repair. Ann N Y Acad Sci (2009) 1.02
Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity. Exp Hematol (2006) 1.02
The effect of tissue adhesive, octyl-cyanoacrylate, on the healing of experimental high-risk and normal colonic anastomoses. Am J Surg (2004) 1.00
Advances in the treatment of testicular cancer. Drugs (2006) 0.99
Adhesion molecules as prognostic markers in pancreatic adenocarcinoma. J Surg Oncol (2007) 0.99
Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis. Cancer Res (2004) 0.98
Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells. Blood (2002) 0.98
Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV. Ann Hematol (2013) 0.98
Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency. Cell Physiol Biochem (2002) 0.97
KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3/CD19-depleted grafts. Ann Hematol (2014) 0.97
Symptomatic bone marrow involvement in breast cancer--clinical presentation, treatment, and prognosis: a single institution review of 22 cases. Anticancer Res (2011) 0.97
Primary adrenal non-Hodgkin's lymphoma: report of two cases. Turk J Gastroenterol (2011) 0.96
Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation. J Cancer Res Clin Oncol (2004) 0.95
Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia. J Clin Oncol (2011) 0.95
VEGF-dependent induction of CD62E on endothelial cells mediates glioma tropism of adult haematopoietic progenitor cells. Brain (2008) 0.94
Mucinous cystadenoma of the appendix: a rare cause of acute abdomen. Ulus Travma Acil Cerrahi Derg (2008) 0.94
Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsets. Ann N Y Acad Sci (2012) 0.94
Complete remission of relapsing high-grade angiosarcoma with single-agent metronomic trofosfamide. Anticancer Drugs (2006) 0.93
Aberrant expression of the homeobox gene CDX2 in pediatric acute lymphoblastic leukemia. Blood (2009) 0.93
SOX2 expression and prognostic significance in ovarian carcinoma. Int J Gynecol Pathol (2013) 0.93
The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma. Cancer (2007) 0.92
Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells. Brain (2005) 0.91
Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemia. Leuk Lymphoma (2005) 0.91
Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias. J Clin Oncol (2003) 0.90
Surgical treatment of liver hydatid cysts. HPB (Oxford) (2006) 0.90
Dendritic cells in vaccination therapies of human malignant disease. Blood Rev (2004) 0.89
Cyclophosphamide for large vessel vasculitis: assessment of response by PET/CT. Clin Exp Rheumatol (2011) 0.89
Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells. Haematologica (2003) 0.89
Scalding in Turkish children: comparison of burns caused by hot water and hot milk. Burns (2006) 0.88
Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning. Br J Haematol (2003) 0.88
Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma. Int J Hematol (2008) 0.88
The CysLT1 ligand leukotriene D4 supports alpha4beta1- and alpha5beta1-mediated adhesion and proliferation of CD34+ hematopoietic progenitor cells. J Immunol (2009) 0.88
Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemia. Ann Hematol (2013) 0.87